Catalyst Pharmaceuticals Inc (CPRX)

May 25, 2026

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

May 25, 2026

May 23, 2026

Technical Reactions to CPRX Trends in Macro Strategies - Stock Traders Daily

May 23, 2026

May 22, 2026

CPRX Stock Price, Quote & Chart | CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) - ChartMill

May 22, 2026

May 20, 2026

Angelini Buyout And FIRDAPSE Settlement Reframe Catalyst Pharmaceuticals Story - Yahoo Finance

May 20, 2026

May 19, 2026

Third Avenue Management's Catalyst Pharmaceuticals Inc(CPRX) Holding History - GuruFocus

May 19, 2026

May 19, 2026

Angelini Pharma to buy Catalyst in deal worth $4.1 billion - MSN

May 19, 2026

May 18, 2026

Catalyst Pharmaceuticals Q1 earnings beat, Firdapse revenues rise Y/Y - MSN

May 18, 2026

May 18, 2026

Angelini Buyout And Firdapse Settlement Reframe Catalyst Pharmaceuticals Story - Sahm

May 18, 2026

May 17, 2026

Catalyst Pharmaceuticals, Inc.Common Stock (NQ: CPRX - FinancialContent

May 17, 2026

May 13, 2026

Angelini Interest Puts Catalyst Pharmaceuticals Rare Disease Value In Focus - Sahm

May 13, 2026

May 13, 2026

Catalyst Pharmaceuticals: Angelini Deal Caps A Potentially Better Story (NASDAQ:CPRX) - Seeking Alpha

May 13, 2026

May 13, 2026

CPRX SWOT Analysis: Strong Financials Amidst Market Challenges R - GuruFocus

May 13, 2026

May 13, 2026

Catalyst Pharmaceuticals (CPRX) Q1 EPS Beat Reinforces High Margin Bull Narratives - Sahm

May 13, 2026

May 12, 2026

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - Yahoo Finance

May 12, 2026

May 12, 2026

Trading the Move, Not the Narrative: (CPRX) Edition - Stock Traders Daily

May 12, 2026

May 12, 2026

Catalyst Pharmaceuticals earnings beat by $0.06, revenue topped estimates - Investing.com Canada

May 12, 2026

May 11, 2026

Catalyst Pharmaceuticals (CPRX) Announces Suspension of Guidance Updates - GuruFocus

May 11, 2026

May 11, 2026

Catalyst Pharmaceuticals, Inc. Q1 2026 earnings preview - MSN

May 11, 2026

May 11, 2026

CPRX Reports Impressive Q1 Revenue Growth - GuruFocus

May 11, 2026

May 11, 2026

Catalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance - TipRanks

May 11, 2026

May 11, 2026

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

Catalyst Pharmaceuticals 1Q EPS 50c >CPRX - Moomoo

May 11, 2026

May 11, 2026

Profit rises at Catalyst Pharmaceuticals (NASDAQ: CPRX) on Q1 2026 results - Stock Titan

May 11, 2026

May 11, 2026

Catalyst Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise - marketscreener.com

May 11, 2026

May 11, 2026

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results - The Manila Times

May 11, 2026

May 11, 2026

Earnings Flash (CPRX) Catalyst Pharmaceuticals, Inc. Reports Q1 Revenue $149.4M, vs. FactSet Est of $149.5M - marketscreener.com

May 11, 2026

May 11, 2026

Earnings Flash (CPRX) Catalyst Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.79 per Share, vs. FactSet Est of $0.65 - marketscreener.com

May 11, 2026

May 11, 2026

Earnings Flash (CPRX) Catalyst Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.79 per Share, Vs. FactSet Est of $0.65 - Moomoo

May 11, 2026

May 11, 2026

BRIEF-Catalyst Pharmaceuticals Q1 Revenue USD 149.4 Million Vs. IBES Estimate USD 148.2 Million - TradingView

May 11, 2026

May 11, 2026

Catalyst Pharma (NASDAQ: CPRX) posts Q1 profit ahead of Angelini deal - Stock Titan

May 11, 2026

May 11, 2026

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Scores 7/10 Fundamental Rating in Affordable Growth Screen - ChartMill

May 11, 2026

May 11, 2026

Angelini Pharma agrees $4.1bn Catalyst Pharmaceuticals acquisition - Yahoo Finance

May 11, 2026

May 10, 2026

Catalyst Pharmaceuticals (CPRX) Set to Report Q1 Earnings with P - GuruFocus

May 10, 2026

May 10, 2026

Catalyst FIRDAPSE Deal Extends Exclusivity To 2035 And Shapes Angelini Bid - Sahm

May 10, 2026

May 10, 2026

Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc.CPRX - The AI Journal

May 10, 2026

May 10, 2026

Vanguard Group Inc. Lowers Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

May 10, 2026

May 10, 2026

Catalyst Pharmaceuticals Buyout And FIRDAPSE Patents Reframe Investor Outlook - Yahoo Finance

May 10, 2026

May 10, 2026

Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1B - MSN

May 10, 2026

May 09, 2026

Family-run Angelini Pharma buys Catalyst Pharmaceuticals for over 4 billion - MSN

May 09, 2026

May 09, 2026

FinancialContentCatalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc.CPRX - FinancialContent

May 09, 2026

May 09, 2026

Catalyst Pharmaceuticals Cut to Neutral From Buy by Citigroup - Moomoo

May 09, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 09, 2026

Citigroup downgrades Catalyst Pharmaceuticals (CPRX) - MSN

May 09, 2026

May 08, 2026

CPRX Downgraded by Citigroup -- Price Target Lowered to $31.50 - GuruFocus

May 08, 2026

May 08, 2026

Citi Downgrades Catalyst Pharmaceuticals(CPRX.US) to Hold Rating, Cuts Target Price to $31.5 - Moomoo

May 08, 2026